Dr. Daniel Salerno Provides Perspective to Medscape on New Data Which Found Baseline Use of PPIs Associated With Future Bronchiectasis Exacerbations

Daniel A. Salerno, MD, MS, Director of RICU Critical Care Services at Temple University Hospital, provided perspective to Medscape on new data presented at the World Bronchiectasis Conference which found baseline use of proton pump inhibitors (PPIs) was associated with future bronchiectasis exacerbations.